What question did this study set out to answer?

This research aims to explore the multifaceted effects of SGLT2 inhibitors on individuals with Type 2 diabetes and their potential organ protective roles.

April 12, 2026Open Access

IV. SGLT2 Inhibitor for Individuals with Type 2 Diabetes

Key Points

This research aims to explore the multifaceted effects of SGLT2 inhibitors on individuals with Type 2 diabetes and their potential organ protective roles.
Analysis of SGLT2 inhibitor mechanisms in diabetes management
Examination of organ protective effects on heart and kidneys
Evaluation of the barriers to appropriate prescription practices.
SGLT2 inhibitors effectively lower blood sugar levels in Type 2 diabetes patients
Increased recognition of their protective roles in cardiovascular and renal health
Management practices highlight delays in initiating appropriate SGLT2 inhibitor therapy.

Abstract

SGLT2阻害薬は血糖降下薬として開発され，現在では心・腎など多彩な臓器保護薬として認識される．SGLT2阻害薬の主たる作用点は近位尿細管であるが，全身的影響の分子機序に関しては様々な仮説が提唱されている．糖尿病合併症に関しては「Post SGLT2 Inhibitor Era」を迎えたと言っても過言ではなく，適切な処方開始が遅れる「医師が残余リスクとなる」ことを厳に避けなければならない．

Bookmark

View Full Paper

Cite This Study

Keizo Kanasaki (Thu,) studied this question.

synapsesocial.com/papers/69db361c4fe01fead37c459e https://doi.org/https://doi.org/10.2169/naika.114.634

Bookmark

View Full Paper